Company Profile for Regenetech, Inc.Regenetech believes its technology solves the major barrier to wide-spread and general clinical use of Adult Stem Cells for a large variety of proven therapies. Over its five years of operation, Regenetech has extended NASA-invented technology to allow Adult Stem Cells separated from peripheral blood peripheral blood Cardiology Blood circulating in the system/body or umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy. samples to be "expanded" (i.e., the population of cells grown) to therapeutic dose level in six to seven days. This is done with the Intrifuge[TM] Bioreactor bioreactor a container in which living organisms carry out a biological reaction. equipped with the NASA-patented Time-Varying Electromagnetic Field electromagnetic field Property of space caused by the motion of an electric charge. A stationary charge produces an electric field in the surrounding space. If the charge is moving, a magnetic field is also produced. A changing magnetic field also produces an electric field. (TVEMF TVEMF Time Varying Electromagnetic Field ) system. In addition, Regenetech is in preclinical veterinary orthopedic trials using the TVEMF system as a Class III medical device for rapid healing of damaged tissue and bone. The Company strategy is to obtain broad international patent coverage of its core technologies and their applications and then to develop the technology for revenue opportunities such as licensing, joint ventures, or direct supply of key markets which do not require Regenetech investment in human clinical trials for early revenues. Near term, the Company is targeting two major areas of regenerative therapy as pathways to commercialization. Each will generate significant cash flow early: Veterinary orthopedics applications of the TVEMF technology for bone healing, and peripheral and cord blood cord blood n. Blood present in the umbilical vessels at the time of delivery. Adult Stem Cell expansion to support clinical trials and stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. banking.
Company: <
Regenetech, Inc.
<
Headquarters Address: <
2801 Post Oak Blvd.
<
Suite 180
<
Houston, TX 77056
<
Main Telephone: <
713-838-5277
<
Website: <
www.regenetech.com
<
Type of Organization: <
Private
<
Industry: <
Health
<
Key Executives: <
CEO: David Bonner
<
Investor and Public Relations <
Contact: <
Timmie Wang
Phone: <
713-838-5277
Email: <
twang@regenetech.com
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion